Patents by Inventor Catherine Marie Germaine Magnan

Catherine Marie Germaine Magnan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9512176
    Abstract: The invention relates to a compound having general formula I, wherein: X represents CH2, C?O, C?S or CHOH, R1 represents an amino acid optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0.1 or 2, or R1 represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0 or 1, or XR1 represent PO3H or SO3H and n=0.1 or 2; R2 represents H, XR1, an alkyl group at C1-C6, an aralkyl group at C1-C6 or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH2, a carboxylic group COOH, one or more halogen atoms.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: December 6, 2016
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Pierre Potier, Guy Jean Marie Potier, Marie-Claude Denise Michele Zelveyan, Catherine Marie Germaine Magnan, Odette Drion, Nobumichi Andre Sasaki, Maria Concepcion Achab Garcia Alvarez, Qian Wang-Zhu, Lioudmila Ermolenko, Joanna Bakala, Gisele Franck, Naima Bakrim Nhiri
  • Publication number: 20120252866
    Abstract: The invention relates to a compound having general formula I, wherein: X represents CH2, C?O, C?S or CHOH, R1 represents an amino acid optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0.1 or 2, or R1 represents a peptide containing two amino acids, each amino acid being optionally substituted by one or more halogen atoms, or by one or more CF3 groups and n=0 or 1, or XR1 represent PO3H or SO3H and n=0.1 or 2; R2 represents H, XR1, an alkyl group at C1-C6, an aralkyl group at C1-C6 or an aryl group, whereby the alkyl, aralkyl and aryl groups can be substituted by an amine NH2, a carboxylic group COOH, one or more halogen atoms.
    Type: Application
    Filed: April 2, 2012
    Publication date: October 4, 2012
    Applicants: Centre National De La Recherche Scientifique (CNRS), PHARMAMENS
    Inventors: Pierre Potier, Guy Jean Marie Potier, Marie Claude Denise Michele Zelveyan, Catherine Marie Germaine Magnan, Odette Drion, Nobumichi André Sasaki, Maria Concepcion Achab Garcia Alvarez, Qian Wang-Zhu, Lioudmila Ermolenko, Joanna Bakala, Gisèle Franck, Naïma Bakrim Nhiri
  • Patent number: 7405309
    Abstract: The invention relates to pyranone derivatives of general formula (I), wherein X is chlorine, bromine or iodine and R1 and R2 is independently a hydrogen atom, an alkyl, cycloalkyl or alkylene, linear or branched group containing 1-20 carbon atoms, optionally substituted by a hydroxyl, amino, ether or halogen group, or R1 and R2 form together a cycle of 5, 6, 7 or 8 members which is optionally substituted by a hydroxyl, amino, ether or halogen group including isomers, enantiomers, diastereoisomers and the mixtures thereof. A method for preparing the inventive derivatives and the therapeutic use thereof, in particular for treating cancer, are also disclosed.
    Type: Grant
    Filed: January 14, 2005
    Date of Patent: July 29, 2008
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Joanna Bakala, Denyse Herlem, Emile Benechie, Jérôme Bignon, Françoise Khuong-Huu, Guy Jean Marie Potier, legal representative, Marie-Claude Denise Michèle Zelveyan, legal representative, Catherine Marie Germaine Magnan, legal representative, Odette Drion, legal representative, Pierre Potier